Two distinct diseases
Atherosclerotic Ras
- ~90% of all RAS
- Older patients with diffuse vascular disease (CAD, PVD)
- Ostial or proximal stenosis
- Slow progression; often discovered incidentally
- Same risk factors as CAD (smoking, lipids, BP, diabetes)
Fibromuscular Dysplasia (Fmd)
- Younger women (20-50 yrs)
- Non-atherosclerotic
- 'String of beads' appearance on imaging
- Mid-to-distal renal artery
- May also affect carotid arteries
- Can present with sudden severe hypertension in a previously well young woman
- Excellent response to balloon angioplasty
Consequences
- Activation of renin-angiotensin → hypertension
- Chronic ischaemia → atrophy of affected kidney
- Flash pulmonary oedema (bilateral RAS or RAS in solitary kidney)
- AKI after ACE/ARB
When to investigate, when to leave alone
INVESTIGATE if:
- Resistant hypertension (failing 3+ drugs including a diuretic)
- BP onset <30 yrs or >55 yrs
- Asymmetric kidney size >1.5 cm difference on USS
- Unexplained AKI after starting ACE inhibitor
- Flash pulmonary oedema
- Abdominal bruit (low sensitivity but specific)
- Diffuse vascular disease + unexplained CKD
- Severe hypertension in a young woman → suspect FMD
Imaging
- Duplex US — first-line, operator-dependent
- CT angiogram — best anatomical detail (avoid in eGFR <30 due to contrast)
- MR angiogram — gadolinium-based (avoid if eGFR <30; macrocyclic agents safer)
- Catheter angiography — only if intervention planned
DO NOT IMAGE if no resistant BP, no AKI, no flash pulmonary oedema — incidentally found RAS rarely benefits from any action.
Kidney Vitality is a daily multivitamin developed by a UK Consultant Nephrologist using renal nutrition principles. It contains no added potassium, magnesium, phosphorus or iron, and no herbal blends. See the formulation.
Treatment
MEDICAL (most patients):
- ACE inhibitor or ARB — yes, even in bilateral RAS, with close monitoring
- Recheck creatinine 1-2 weeks after starting; accept ≤30% rise
- Statin (atorvastatin 20-40 mg)
- Antiplatelet (aspirin or clopidogrel)
- BP target <130/80
- Stop smoking
- Tight diabetes/lipid control
INTERVENTION (selected cases):
- FMD — primary angioplasty WITHOUT stent; ~70% are cured of hypertension
- Atherosclerotic — stent ONLY for:
- Rapidly deteriorating renal function with bilateral disease or solitary kidney
- Flash pulmonary oedema
- True resistant hypertension on ≥4 maximally-dosed drugs
- Risks: cholesterol embolisation (livedo, AKI, blue toes), restenosis, contrast nephropathy, dissection
SURGICAL bypass — historical; rarely done.
Follow-up
- 3-monthly U&E in the first year
- 6-12 monthly USS to monitor kidney size
- BP review (home monitoring)
- Cardiovascular risk: smoking cessation, statin, BP, glycaemic control
- Address co-existent renal failure (CKD-MBD, anaemia, vaccinations) as for any CKD patient
FMD-specific:
- Carotid imaging — FMD often multivessel
- Brain MRA — screen for intracranial aneurysms
- Vascular Society of Great Britain & Ireland registry referral
NEPHROLOGY REFERRAL: all confirmed RAS cases — even if managed medically — for risk stratification and long-term planning.






